Amlexanox, a selective inhibitor of IKBKE, generates anti-tumoral effects by disrupting the Hippo pathway in human glioblastoma cell lines
2017 ◽
Vol 8
(8)
◽
pp. e3022-e3022
◽
Keyword(s):
2005 ◽
Vol 71
(3)
◽
pp. 237-243
◽
Keyword(s):
2015 ◽
Vol 758
◽
pp. 177-187
◽
2012 ◽
Vol 318
(15)
◽
pp. 1901-1912
◽